Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man

The Journal of Clinical Investigation
W D ZollingerS L Berman


A noncovalent complex of meningococcal group B polysaccharide and type 2 outer membrane protein has been characterized and its potential as a vaccine against group B meningococcal disease investigated. The polysaccharide component was found to have a partition coefficient, K(d), of 0.34 on Sepharose CL-4B in the presence of sodium deoxycholate. The protein consisted of four to five major proteins including the principal outer membrane protein. Hydrophobic binding between the protein and polysaccharide was demonstrated by gel filtration and isopycnic CsCl density gradient centrifugation and found to involve all of the proteins. After demonstrating safety and immunogenicity in animals, two lots of vaccine were tested in a total of eight volunteers. Two 120-mug doses were given subcutaneously at 0 and 5 wk. Mild local reactions occurred in all eight volunteers, but no systemic reactions were observed. 2 wk after the first dose, six of the volunteers had increased levels of bactericidal antibodies against both the group B polysaccharide and the outer membrane proteins. Antibody rises to the group B polysaccharide (mean 6-fold) were confirmed by passive hemagglutination assays and rises to the proteins (mean 10-fold) by a solid phas...Continue Reading


Jun 1, 1978·The Journal of Infectious Diseases·W D ZollingerM S Artenstein
Aug 1, 1977·The Journal of Infectious Diseases·P Anderson, D H Smith
Jan 1, 1977·Journal of Biological Standardization·K H WongE B Seligmann
Sep 1, 1977·Journal of Clinical Pathology·A SivonenJohn Robbins
Aug 1, 1976·Journal of Clinical Pathology·D M Jones, B M Tobin
Apr 1, 1973·The Journal of Infectious Diseases·D L KasperM S Artenstein
Jul 1, 1974·The Journal of Experimental Medicine·C E Frasch, E C Gotschlich
Nov 1, 1972·The Journal of Infectious Diseases·F A WyleJ P Lowenthal
Sep 25, 1967·JAMA : the Journal of the American Medical Association·M S ArtensteinE L Buescher
Apr 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·D L KasperS B Formal
Mar 18, 1969·Biochimica Et Biophysica Acta·C F Brunk, V Leick
Jun 1, 1969·The Journal of Experimental Medicine·I GoldschneiderM S Artenstein
Jun 1, 1969·The Journal of Experimental Medicine·I GoldschneiderM S Artenstein
Apr 1, 1970·The Journal of Infectious Diseases·M S ArtensteinC Harkins


Dec 1, 1985·European Journal of Clinical Microbiology·C E Frasch
Mar 1, 1988·Indian Journal of Pediatrics·R Merchant, R Divekar
Jan 1, 1991·Transactions of the Royal Society of Tropical Medicine and Hygiene·J M GriffissJ J Kim
Sep 1, 1996·FEMS Immunology and Medical Microbiology·M G DanelliC E Frasch
Jul 21, 1984·Lancet·W D ZollingerL O Froholm
Jan 25, 1986·Lancet·M R Lifely, C Moreno
Sep 29, 2001·Journal of Microbiological Methods·G B Lesinski, M A Westerink
May 29, 1999·International Journal of Immunopharmacology·R Tarrab-HazdaiR Arnon
Feb 13, 2001·Vaccine·A J Pollard, C E Frasch
Dec 12, 2001·Vaccine·S L Morley, A J Pollard
Oct 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·John RobbinsMark A Miller
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·M A WesterinkT Kieber-Emmons
Aug 1, 1980·The Journal of Experimental Medicine·Rachel SchneersonJohn Robbins
Feb 1, 1988·The Journal of Experimental Medicine·G H LowellW D Zollinger
May 1, 1990·The Journal of Experimental Medicine·R E MandrellM A Apicella
Feb 1, 1997·Hybridoma·T Kieber-EmmonsZ Steplewski
Feb 11, 2005·Omics : a Journal of Integrative Biology·Daniela BumbacaMark J Jedrzejas
Apr 27, 2000·The Pediatric Infectious Disease Journal·A J Pollard, M Levin
Dec 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·H SjursenC O Solberg
Jan 19, 2006·Clinical Microbiology Reviews·Lee H Harrison
Jun 29, 2002·Archives of Disease in Childhood·A J Pollard, E Richard Moxon
Nov 1, 1981·The Journal of Clinical Investigation·J P PandeyC B Loadholt
Jan 1, 1987·Antonie van Leeuwenhoek·W D ZollingerB L Brandt
Jan 1, 1984·Infection·P H Mäkelä
Feb 2, 2010·The Lancet Infectious Diseases·Manish Sadarangani, A J Pollard
Apr 4, 2017·Pathogens and Disease·Myron Christodoulides, John Heckels
Jan 1, 1981·Critical Reviews in Microbiology·J E Sippel
Aug 3, 2016·Infection and Immunity·Afshin ZaririPeter van der Ley
Jul 1, 2015·International Journal of Evidence-based Healthcare·Helen MarshallAndrew J Pollard
Nov 3, 2006·Clinical and Vaccine Immunology : CVI·Samuel MooreFrancis Michon
Mar 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michele M EstabrookGary A Jarvis
Dec 1, 1987·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·H SjursenC O Solberg
Oct 5, 2018·Microbial Cell Factories·Matthias J H GerritzenMichiel Stork
May 4, 1999·Infection and Immunity·A J PollardM Levin
May 4, 1999·Infection and Immunity·A J PollardM Levin

Related Concepts

Antibodies, Bacterial
Bacterial Proteins
Bacterial Vaccines
Cavia porcellus
Cell Surface Proteins
Neisseria meningitidis
Polysaccharides, Bacterial

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

The Tendon Seed Network

Tendons are rich in the extracellular matrix and are abundant throughout the body providing essential roles including structure and mobility. The transcriptome of tendons is being compiled to understand the micro-anatomical functioning of tendons. Discover the latest research pertaining to the Tendon Seed Network here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.


Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Long COVID-19

“Long Covid-19” describes illness in patients who are reporting long-lasting effects of the SARS-CoV-19 infection, often long after they have recovered from acute Covid-19. Ongoing health issues often reported include low exercise tolerance and breathing difficulties, chronic tiredness, and mental health problems such as post-traumatic stress disorder and depression. This feed follows the latest research into Long Covid.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.